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Abstract 
Chronic inflammation is a fundamental condition underlying many human disease 
pathologies including diabetes, cancer, and neurodegeneration. Indeed, one of the most 
commonly-used anti-inflammatory drugs, aspirin, has been shown to be effective in the treatment 
of many cancers. To understand the mechanistic linkages between inflammation and cancer, we 
used Drosophila models in which hyperactive immune signaling causes overproliferation of the 
hematopoietic system leading to the production of inflammatory blood tumors. In mutant 
animals, hematopoietic cells divide uncontrollably and exhibit pre-mature differentiation giving 
rise to large sticky cells. Some mutant cells infiltrate and adhere to cells of the fat body. The fat 
body is a large organ in fly larvae and akin to the mammalian liver. In wild type larvae, 
hematopoietic cells exhibit limited rounds of division, and circulating cells in the hemolymph do 
not stick to fat body. Our hypothesis was that if the biochemistry and genetic circuitry underlying 
inflammation biology in flies is conserved, then aspirin administration should have the same 
therapeutic effects on tumor growth and infiltration in fly mutants as it does in humans.  
  Here we show that sublethal levels of systemically-administered aspirin improve viability 
of mutants and reduce the size and abundance of blood tumors. The accompanying infiltration of 
blood cells on larval fat body cells of mutants is also reduced. These results support our 
hypothesis and suggest that the mechanisms underlying aspirin’s effects in flies may be similar 
with those in mammals. These studies underscore the value of the Drosophila model system and 
present exciting possibilities for uncovering shared mechanisms.  
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Introduction  
Inflammation is a fundamental innate immune reaction that occurs in response to injury 
or infection and is characterized by cell proliferation and migration [1]. The highly conserved 
transcription factor NF-κB regulates the expression of genes involved in inflammation and 
immunity [1, 2]. High levels of NF-kappa B signaling and high cyclooxygenase enzymatic 
activity are two major culprits of cancer and chronic inflammation [2, 3]. Pro-inflammatory 
cytokines signal the downstream IKK kinases that phosphorylate the NF-κB/Toll inhibitors 
IκB/Cactus, prompting their ubiquitination and degradation [3, 4]. Free NF-κB dimers 
translocate to the nucleus and induce the expression of target genes [5]. In mammals, NF-κB 
target genes include the inducible Ptgs2 that encodes the cyclooxygenase 2 (COX-2) enzyme [6, 
7]. COX-2 and its isoform COX-1 (encoded by Ptgs1) metabolize arachidonic acid into 
prostaglandin G2 that is subsequently converted into one of five main prostanoids. Some of these 
prostanoids are pro-inflammatory [8, 9]. Aspirin reduces inflammation by inhibiting the COX-1, 
COX-2, as well as IKK-β, thereby inhibiting the transcriptional activation of NF-κB [10].  
Genetic studies in mice have revealed the multiple and unique roles of COX-1 and COX-
2 in organ function, development, and inflammation. The multiplicity of these functions arises 
from the differential expression of Ptgs1 and Ptgs2, the specific prostaglandin produced, and 
their autocrine/paracrine effects [6].   Consequently, aspirin’s effects on specific cells and 
biological processes are numerous, complex, and in some cases even contradictory. For example, 
while COX-2 inhibitors reduce the risk of cancers in the colon, breast, prostate and lung [6], 
genetic  studies support an anti-inflammatory role for COX-2 in preventing pulmonary 
fibrogenesis [11].  
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To overcome the physiological complexity of inflammation in mammalian models and 
obtain deeper insights into the biochemistry of aspirin’s anti-inflammatory effects, we are using 
Drosophila, a simple and cost-effective model in which acute and chronic inflammation with key 
cellular and molecular features of mammalian inflammation [12]. In both mammals and flies, 
acute inflammation results from the activation and resolution of innate immune signaling (NF-κB 
and JAK-STAT pathways [13-15] and is characterized by the proliferation, differentiation, and 
recruitment of blood cells to the site of injury [16]. Chronic inflammation sets in when immune 
signaling fails to resolve [1 [12].  
One mechanism essential for proper termination of inflammation in both flies and 
mammals is sumoylation, a conserved post-translational protein modification pathway [12, 17]. 
Drosophila mutants lacking the function of the SUMO-conjugating enzyme Ubc9 exhibit 
ectopic, unresolved NF-κB signaling because of lower IκB/Cactus levels [12]. Ubc9 animals 
endure extreme over-proliferation of blood cells and develop dense hematopoietic tumors, 
composed mainly of differentiated plasmatocytes and lamellocytes. Excessive blood cells also 
infiltrate the fat body [12].  Similar to Ubc9, gain of function mutations in the hopscotch
Tum-l
 
gene of the Jak-Stat pathway also result in chronic inflammation [18] [19] [20].  
The goal of this study was to determine if Ubc9 and hop
Tum-l 
mutant larvae are sensitive 
to commercially available aspirin (acetyl salicyclic acid) when supplied in their food. We 
examined tumor burden and viability of these animals and report clear anti-inflammatory effects 
of aspirin in both genetic backgrounds. These results suggest that the biochemistry and genetics 
of inflammation in flies is more similar to mechanisms in mammals than previously anticipated. 
Our system provides a powerful context to discover such highly-conserved but poorly-
understood aspects of inflammation biology.  
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Materials & Methods 
Fly strains and culture 
Mutant lines: y v; hop
Tum-l




and y w; Ubc9
5
/CyO y+ alleles are described in [22]. 
UAS and Gal4 lines: The UAS/Gal4 system [23] was utilized for the expression of candidate 
proteins. Msnf9-Gal4 [24] was a gift from R. Schulz.  UAS-mCD8-GFP (stock # 5137) line was 
also used as a reporter for lamellocytes. 
All crosses were kept at 25°C for 24-48 hour egg lays unless specified otherwise. 
Comparison of phenotypes was done with animals treated exactly and on the same day.  
 
Steps involved in creating the y w hop
Tum-l 
msnf9-Gal4/FM7; UAS-mCD8-GFP strain: 






 and y v hop
Tum-l 
/ Y males 
were crossed. From the progeny, virgin females in which y w msnf9-Gal4 was in trans to y v 
hop
Tum-l
 were selected and crossed to y w / Y males. Putative male recombinants having possibly 
incorporated msnf9-Gal4
w+
 in cis to hop
Tum-l
 were screened on the basis tumors and w+ eye 
color. These putative recombinant males y w v msnf9-Gal4
w+
in cis to hop
Tum-l







[16] female virgins. Then 
















/+] from this cross were selected based on yellow body color and the 
expression of mCD8-GFP in tumors. These flies were allowed to self cross and animals 
homozygous for UAS-mCD8-GFP
w+ 
on the second chromosome were screened.  
  




Genotyping larvae  
In the hop
Tum-l
 experiments, larvae were scored for GFP to ensure the presence of the 
Tum-l recombinant chromosome otherwise they were assumed to carry the FM7 balancer 
chromosome. Similarly, in the Ubc9 experiments, larvae were scored for lighter colored “yellow” 
mouth hooks to ensure the presence of both mutant alleles of the Ubc9 gene otherwise assumed 
to carry only 1 copy of the mutation. 
 
Aspirin treatment 
Aspirin (acetyl salicylic acid, Sigma) stock solution was prepared in DMSO to maintain 
stability. The stock solution was diluted to either to 1 nM or 50 nM in 5 mL semi-solid fly food 
so that DMSO levels do not exceed 3% as flies cannot tolerate higher levels [25].  This solution 
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was reconstituted into already cooked fly food via a pestle grinder attached to a micro-spatula. 
Aspirin solution was always made fresh. Animals received the drug from the time they hatched 




 crosses were cultured in 
either aspirin-treated, or DMSO control vials at 25°C.  
 
Hemocyte infiltration index, tumor penetrance and expressivity measurements 
Hemocyte infiltration in larval fat body tissues was scored after dissection at a 
magnification of 200 X. Fat body from control and experimental animals was dissected, fixed, 
stained with Hoechst and rhodamine labeled phalloidin, and then mounted with 0.04% n-propyl 
gallate in 50% glycerol and 1% PBS in distilled water. The number of single blood cells 
adhering to the top and bottom of the fat body were scored using a Zeiss Axioscope fluorescence 
microscope or Nikon Inverted fluorescence microscope. Aggregates attached to the fat body 
were not scored.  
Tumor penetrance was scored for melanized microtumors through the cuticle in intact 
animals (at a magnification of 50 X). Since tumor penetrance is inherently variable, for well-
controlled conditions and comparable results, animals were grown and scored simultaneously 
under the same conditions. Since there is no mCD8-GFP in the Ubc9 genetic background, 
infiltration was examined by the presence of diploid nuclei and cells staining high for F-actin in 
the vicinity of the polyploid fat body nuclei. Penetrance is defined as the number of experimental 
class individuals exhibiting one or more tumor. Expressivity is the degree or severity of the 
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Viability assays of adult flies  
The expected viability of hop
Tum-l
 mutants is represented by comparing the observed 
viability of the FM7 (wild-type siblings of hop
Tum-l 
mutants). The viability of these FM7 (internal 
control) animals was normalized to 100%.  
 
Preparation of samples for microscopy 
Cells from the hemolymph or fat body from developmentally-synchronized larvae were 
collected, fixed with 4% paraformaldehyde (pH 7.4). Fixed samples were dissected on 
microscope slides were washed 3 times with 1% PBS. Then, samples were stained with nuclear 
dye Hoechst 33258 (Invitrogen) and rhodamine-labeled phalloidin (Invitrogen), Stained samples 
were mounted in 0.04% n-propyl gallate in 50% glycerol and 1% PBS in distilled water. Images 
were obtained using a Zeiss LSM510 confocal microscope, or a Zeiss Axioplan 2 equipped with 
fluorescence optics or a Nikon Inverted fluorescence microscope. Images for control and 
experimental samples were taken at identical settings.  
 
Statistical analysis 
Data were placed into categories comparing varying degrees of inflammation. This 
categorization represented a range of levels in the tumor phenotypes. A Chi-square 
test was used to assess goodness to fit between observed versus 
expected values.  The null hypothesis was that there is no association between drug treatment 
and viability or drug treatment and tumor size. To document variation in hemocyte infiltration, 
standard deviation of the mean was computed. 
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Results and Discussion 
Aspirin reduces tumor burden and infiltration in Ubc9 mutants 
Compared to their heterozygote siblings (Fig 1A), hemolymph smears from third instar 
Ubc9 mutants (Fig 1B) produce numerous blood cells that are large in surface area with cellular 
extensions rich in polymerized F-actin [22, 26]. The differentiation of these larger and highly-
adherent cells (lamellocytes) is induced upon infection or in mutants with ectopic immune 
signaling [16]. Aspirin was systemically administered to control and Ubc9 mutants. Control 
larvae (y w) treated with aspirin (1 nM and 50 nM) had no significant difference in their 
development, blood or fat body cell morphologies (data not shown).  
Compared to untreated siblings, undissected larvae treated with aspirin displayed an 
overall decrease in the abundance and size of melanized aggregated masses. At higher aspirin 
concentration (50 nM), there was a substantial decline in tumor penetrance (Fig 2A, p<0.06) and 
no melanized tumors were evident in animals treated with the lower 1 nM aspirin concentration 
(Fig 2A, p<0.004). 
Hemolymph contents were then characterized from dissect animals as “aggregates” (less 
than 50 cells) or tumors (structures of more than 50 cells but do not exceed 1 mm
3
; Fig 3A). 
Aspirin (1 nM and 50 nM ) treatment alleviated tumorogenesis (Fig 3B, C): In untreated mutants, 
larval hemolymph from less than 3% of the animals was free of aggregates and tumors, while in 
aspirin treated animals, almost 30% of the animals were free of aggregates and tumors 
(p<0.002). Less than 20% of mutant animals treated with aspirin had multiple large tumors 
compared to over 66% of untreated mutants (p<0.002). 
Consistent with this reduction in tumor penetrance and expressivity, we found an 
extensive decrease in hemocyte infiltration of the fat bodies after aspirin treatment, rescuing the 
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phenotype back to wild-type at both 1 nM and 50 nM concentrations (Fig 4). In Ubc9 mutants, 
about 250-300 hemocytes adhere to 100 fat body cell, compared to only 30 hemocytes per 100 
fat body cells in the wild-type controls (Fig 4).  Yet, in Ubc9 mutants treated with different 
concentrations of aspirin, we found only 18 (1 nM, SD<0.05) to 32 (50 nM, SD<0.03) 
hemocytes per 100 fat body cells adhering to the fat body (Fig 4).  
 
Aspirin reduces tumor burden in hop
Tum-l
 mutants 
We next examined if the effects of aspirin are similar in other genetic backgrounds with 
chronic inflammation. hop
Tum-l
, a dominant gain of function mutation in the hopscotch gene of 
the JAK-STAT pathway results in a major increase in lamellocyte differentiation and 
aggregation into melanized microtumors in the absence of infection [27].  
The hop
Tum-l
 mutant background has some advantages in comparison to the heteroallelic 
combination of Ubc9. The hop
Tum-l
 mutant allele is semi-dominant and temperature sensitive 
(permissive at 18
o
C, non permissive at 25-29
o
C); it is X-linked and semi-lethal, so viability can 
also be studied. We labeled lamellocytes in live animals utilizing the UAS-Gal4 system. 
Misshappen (msn) encodes a protein kinase within a JNK pathway and contains an enhancer that 
is active in lamellocytes [24]. Thus, a misshapen driver and a UAS-mCD8-GFP (membrane 
targeted GFP) marker were incorporated into the hop
Tum-l
 genetic background (Fig 5).  
At 25
o
C, aspirin treatment improved viability from 35% in untreated hop
Tum-l
 mutants to 
69% with only 1 nM, but not at 50 nM or 100 nM aspirin concentrations (Fig 6, p<0.003). 
Tumor penetrance and expressivity were not significantly reduced in this background (Fig 6) 
likely due to a highly malignant effect of the mutation.  
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Arachidonic acid (AA) conversion into eicosanoids is the most commonly investigated 
metabolic pathway mediated by COX. However, the COX enzymes also metabolize several other 
long-chain polyunsaturated fatty acids including eicosapentaenoic, linolenic, and linoleic acids 
[6]. Flies appear to lack C20 and C22 polyunsaturated fatty acids [28] and only one cyclo-
oxygenase-like enzyme [29] has been reported to date. Despite these biochemical and genetic 
differences between flies and mammals, aspirin’s anti-inflammatory and anti-tumor effects are 
strikingly similar to those in humans [30-32].  
Recent biochemical experiments revealed a novel mechanism by which aspirin facilitates 
the COX-2-mediated conversion of omega-3 and omega-6 fatty acids into anti-inflammatory 
molecules. Among these, 13-HODE (hydroxyoctadecadienoic acid) is the most important [33]. It 
is possible that anti-inflammatory/anti-tumor effects of aspirin are mediated by this latter 
mechanism and ongoing experiments are geared toward testing this hypothesis.  
Aspirin is one of the most widely-used medications in the world for its analgesic, anti-
inflammatory properties, and cardiovascular benefits [34].  It blocks the two most common and 
closely-linked mechanisms underlying chronic inflammation, i.e., NF‐κB signaling and 
eicosanoid‐mediated signaling. Proteins involved in these pathways are candidates for 
therapeutic drug targeting [35]. Ongoing experiments in our lab also seek to identify aspirin 
protein targets to explain it’s biological and biochemical effects. These studies will have strong 
and broad predictive value and will  clarify the mechanistic relationship between inflammation 









Figure 1: Hemolymph of control and Ubc9 animals 
Cells were stained with Hoechst (DNA, blue) and Phalloidin (F-actin, red).  
 
(A) Hemocytes from heterozygous Ubc9 animals, and (B) 8 day-old 4-3/5 Ubc9 mutants. Larger 
lamellocytes are present only in Ubc9 mutant hemolymph (B). Scale bars measure 10 µm in 
panels (A) and (B) showing same magnification.  
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Figure 2: Aspirin reduces tumors in intact Ubc9 mutant larvae 
 
Intact (not dissected) third instar larvae were scored for the effects of aspirin on tumor size and 
abundance. Genotypes of animals and aspirin concentrations are indicated. Wild type y w 
animals do not have any tumors. All Ubc9 mutants have tumors.  
 
Numbers of larvae scored are displayed within each bar. A significant (P<0.01) response to 
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   F-actin     DNA 
Figure 3: Aspirin reduces tumorgenesis in Ubc9 mutant larvae 
 
(A) Tumor penetrance and expressivity from dissected animals. Genotypes of animals and 
aspirin concentrations are indicated. y w animals do not have any tumors whereas all Ubc9 
mutants have tumors or aggregates. Numbers of larvae scored are displayed within each bar.  
 
(B-C) Tumor from Ubc9 mutant (B, distilled water) and aspirin-treated (C, 1 nM) animals.  
Scale bars in panels B and C represents 100 µm.  
A 
  







y w Ubc9 Ubc9 -/-                     
Aspirin 1 nM 
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F-actin     DNA 
Figure 4: Aspirin reduces metastasis in Ubc9 mutant larvae 
 
(A) Hemocytes infiltration into fat body organ. Fat body from third instar larvae were isolated 
and stained. Infiltration index represents the number of hemocytes per 100 fat body cells 
adhering to the fat body organ. y w animals baseline numbers of blood cells in contact with fat 
body while fat body from 10-day old Ubc9 mutants is infiltrated. Numbers of larvae scored are 
displayed within each bar. Bars show standard error. 
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Figure 5: Characterization of the hop
Tum-l
 recombinant reporter/driver line 
 
(A-C) y v hop
Tum-l 
; mCD8-GFP / mCD8-GFP animals. 
 
(A) Hemolymph isolated from third instar larvae. Cells were stained with Hoechst (DNA, blue); 
and phalloidin (F-actin, red). misshapen>mCD8-GFP labels lamellocytes. Arrows point to 
different hematopoietic cell types and cluster of hemocytes (small tumor).  
(B) Intact third instar larvae visualized under light microscopy at 100x magnification. 
Arrowheads point to melanized specks. Arrows point to melanized tumors.  
(C) Intact third instar larvae visualized under fluorescence microscopy at 100x magnification.  
  
  




Figure 6: Aspirin increases viability and reduces cancer burden in hop
Tum-l
 larvae 
Tumor penetrance, expressivity and viability were scored at three aspirin concentrations as 
indicated. Control FM7 animals do not have any tumors. Numbers of animals scored are 
displayed within each bar. The viability of the FM7 (wild-type siblings of hop
Tum-l 
mutants) has 
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